The Wide-Awake-at-3-AM Man

Sleep, obstructive sleep apnea, and the nocturnal sympathetic surge your smartwatch didn’t tell you about

You wake up at 3:17 a.m. and you know, immediately, completely, that you will not go back to sleep. The mind is already working — not dreaming, working. The items on the morning agenda materialize without being summoned. There is a specific quality to the alertness at this hour that has nothing peaceful about it — a kind of charged, joyless wakefulness that feels like being ambushed by your own nervous system. You have learned to call this insomnia, or stress, or the price of a demanding life, and you have incorporated it so thoroughly into your operating baseline that you no longer experience it as a problem. It is just how things are right now.

I want to offer a different clinical interpretation. In at least half the men I see who describe this pattern, what they are experiencing is a nocturnal sympathetic surge — the stress response system activating in the early hours of the morning when cortisol is supposed to be at its lowest point, and when the heart and blood vessels are supposed to be in their deepest rest. What is actually happening during these wakeups, in cardiovascular terms, is a measurable spike in heart rate, a rise in blood pressure, a wave of catecholamines, and a disruption to the nocturnal blood pressure dip that cardiologists consider one of the most important protective mechanisms the sleeping body has. You have been having a cardiovascular event — a small one, night after night — and calling it a bad night’s sleep. This chapter is about why that distinction matters, what is driving it, and what to do about it before it matters more.

Before I get to the mechanisms, I want to be honest about something. The 3 a.m. wakeup is one of the most common complaints I hear from men in their forties and fifties, and it is also one of the most commonly dismissed — by the man himself, sometimes by his physician, and almost always by the ambient cultural narrative that equates broken sleep with effort and ambition. I understand that narrative. I have lived some version of it. But I have also seen what sleep deprivation looks like on an echocardiogram over time, and I have stopped finding the narrative compelling.

What Sleep Is Actually Doing to Your Heart

Most people understand sleep as rest — the body going offline, the mind doing whatever the mind does in dreams. This is not wrong exactly, but it misses the most clinically significant thing that happens when you sleep, which is what sleep does for your cardiovascular system.

During normal, consolidated sleep, your body progresses through cycles lasting roughly ninety minutes. Each cycle contains stages of non-rapid eye movement sleep — NREM, divided into lighter Stage 1 and Stage 2, and the deep, restorative Stage 3 also called slow-wave sleep — followed by rapid eye movement sleep, or REM. A man getting seven to eight hours of sleep will cycle through this architecture four to six times per night. The clinical significance of each stage is different, and it matters.

During slow-wave sleep — the deep NREM stage that dominates the first half of the night — your heart rate slows, your blood pressure drops, and your sympathetic nervous system, which drives the fight-or-flight response, pulls back to its lowest activity level of the day. Growth hormone is secreted in surges during this stage. Testosterone production is predominantly sleep-dependent, with the majority of daily testosterone synthesis occurring during sleep, particularly during the early slow-wave phases. Your immune system does a substantial portion of its repair work here. Glucose metabolism is regulated. Inflammatory cytokines are managed.

During REM sleep — which dominates the second half of the night — the brain processes emotional memory, consolidates learning, and cycles through a state of relative autonomic instability: brief periods of elevated heart rate and variable blood pressure punctuate the otherwise quieter cardiovascular state. This is normal and functional. REM is where emotional regulation happens, and it matters not just psychologically but physiologically, because the man who doesn’t get adequate REM carries more emotional reactivity into his waking life, which means more sympathetic activation, which means higher average cortisol and catecholamines throughout the day.

The reason all of this matters is what happens in parallel — the blood pressure dip.

The Non-Dipper and the Riser

In a healthy individual, systolic blood pressure drops by ten to twenty percent during sleep compared to waking levels. This is called the nocturnal dip, and it is not incidental. Cardiologists consider the nocturnal dip one of the most important markers of cardiovascular health that almost nobody talks about outside specialty practice.

The dip occurs because the parasympathetic nervous system — the rest-and-digest counterpart to sympathetic fight-or-flight — takes over during sleep, reducing cardiac output and allowing the vascular system to recover from the pressure demands of the waking day. This nightly pressure reduction is protective for the heart muscle, the kidneys, and the brain. It gives the arterial walls a genuine mechanical rest.

Men who fail to achieve this dip are called non-dippers. Men whose blood pressure actually rises during sleep — which does happen — are called risers or reverse-dippers. Both patterns are associated with significantly elevated cardiovascular risk, independent of what their daytime blood pressure readings show. The non-dipper can walk into a physician’s office with blood pressure of 128/82 and be told he’s doing fine, because the office blood pressure doesn’t capture what’s happening during the seven or eight hours he’s supposed to be sleeping.

A 2021 analysis published in JAMA Cardiology estimated that approximately 22.7 percent of U.S. adults have masked asleep hypertension — blood pressure that is elevated during sleep but appears normal in clinical measurement. Among men specifically, that prevalence was 27 percent. This means roughly one in four American men has blood pressure behavior during sleep that his physician has almost certainly never seen and has no reason to suspect based on standard office visits.

The clinical consequence is not abstract. Non-dipping independently predicts stroke, myocardial infarction, left ventricular hypertrophy, and chronic kidney disease after controlling for daytime blood pressure levels. The kidney damage deserves special mention: the kidney relies on the nocturnal pressure reduction for its own recovery, and the man whose pressure doesn’t dip appropriately is running his kidneys at full load around the clock.

What causes non-dipping? Several things, and they interact. Obstructive sleep apnea — which we’ll get to in detail — is one of the most common causes. Chronic sympathetic nervous system overactivation, driven by chronic stress and HPA dysregulation, is another. Autonomic neuropathy from long-standing diabetes is a third. And simply having had poor-quality sleep for years, producing a state of sustained low-grade sympathetic tone that doesn’t fully release even at night.

Why You Wake at 3 a.m.: The HPA Axis at Night

To understand the 3 a.m. wakeup, you need to understand the diurnal rhythm of cortisol — what it’s supposed to do across a twenty-four-hour cycle, and what chronic stress does to that rhythm.

In a healthy adult, cortisol follows a reliable daily arc. It is lowest in the evening and first half of the night — ideally below five nanomoles per liter around midnight. Around three to four in the morning, as part of a precise circadian signal, the hypothalamus begins instructing the adrenal glands to ramp up cortisol production. This is intentional and functional: it prepares the body to transition from sleep to waking, mobilizing glucose, sharpening alertness, and activating the cardiovascular system for the demands of the day. The cortisol awakening response — a sharp peak in cortisol occurring in the thirty to forty-five minutes after natural waking — is the final phase of this preparation.

The problem for the chronically stressed man is that this process has been dysregulated. A 2003 study by Pruessner and colleagues published in the Journal of Clinical Endocrinology & Metabolism demonstrated that men with high cortisol awakening responses — an early, exaggerated morning cortisol spike — had significantly higher systolic blood pressure throughout the day. More critically, in men under chronic occupational and psychological stress, the nocturnal cortisol trough is no longer deep. The hypothalamic-pituitary-adrenal axis, which is supposed to be in a quiet phase between midnight and three, has been calibrated by months or years of stress to maintain a higher baseline. The signal that initiates the morning cortisol ascent begins earlier, the ascent is steeper, and the man who is supposed to be in deep restorative sleep at three in the morning is instead experiencing a premature cortisol surge accompanied by sympathetic activation.

This is what the 3 a.m. wakeup actually is, in many cases: not insomnia in the conventional sense, but the body’s stress response system firing on a schedule it developed under duress, and which it has not yet been persuaded to revise.

The cardiovascular consequences are immediate. When cortisol rises, so does heart rate and blood pressure. Catecholamines follow. The arterial endothelium, which had just entered its recovery phase, is back under pressure load. And the man lying in bed with his mind already running the Monday morning agenda is not getting slow-wave sleep — the sleep that makes testosterone, regulates insulin, and provides the genuine cardiovascular rest that the dip was supposed to provide.

The literature on this morning cortisol and cardiac event timing is striking. Data from the Mostofsky group published in the European Heart Journal has consistently documented that myocardial infarction incidence peaks on Monday mornings between six and ten a.m. — the window that coincides precisely with peak cortisol and sympathetic activation following a weekend of irregular sleep and the anticipatory stress of returning to work. The physiological pattern that produces the 3 a.m. wakeup is the same pattern that concentrates cardiac events in the morning. They are different expressions of the same HPA dysregulation.

Obstructive Sleep Apnea: The Cardiovascular Accelerant You Haven’t Diagnosed

The 3 a.m. wakeup and the cortisol story are important. But I want to spend real time on the condition that produces all of this — and more — in an exaggerated and often undiagnosed form. Obstructive sleep apnea is the single most clinically urgent sleep-related issue in men between thirty-five and fifty-five, and it is vastly underdiagnosed.

The American Academy of Sleep Medicine estimates that obstructive sleep apnea affects approximately twelve percent of American adults — roughly 29.4 million individuals — and that more than eighty percent of these cases remain undiagnosed. Among men specifically, particularly overweight men in the thirty-five to fifty-five age range, estimated prevalence is twenty to thirty percent. I see this every week in my clinic, and I see it in a specific form: the man who is told by his wife or partner that he snores, occasionally stops breathing, and wakes suddenly — who has mentioned this to his physician in passing or not at all, and who describes his own sleep as “okay” or “fine.”

The mechanism of obstructive sleep apnea is worth understanding in some detail, because once you understand it, the cardiovascular consequences stop being surprising. OSA occurs when the muscles of the upper airway relax during sleep, allowing the soft tissue — primarily the tongue and the soft palate — to partially or fully obstruct the airway. This obstruction prevents adequate airflow, causing blood oxygen to drop. The brain detects hypoxia, triggers an arousal response to restore muscle tone and reopen the airway, the oxygen level recovers, and the cycle repeats. Moderate to severe OSA produces this sequence five to thirty or more times per hour, all night, every night.

Each oxygen desaturation event produces a sympathetic surge. The brain’s hypoxia response is mediated by the same system as the stress response — catecholamines rise, heart rate jumps, blood pressure spikes. The man with an AHI — apnea-hypopnea index, the measure of events per hour — of twenty-five is experiencing roughly four hundred sympathetic activation events per night. By morning, his nocturnal blood pressure has not dipped; it has been episodically elevated hundreds of times. His cortisol is elevated. His heart rate variability, which should be high after a night of restorative sleep, is suppressed. And he has very likely told himself the fatigue he feels is from being busy, not from receiving none of the cardiovascular recovery he was supposed to get.

The downstream consequences accumulate. A 2024 state-of-the-art review published in the Journal of the American College of Cardiology by Javaheri and colleagues synthesized the current mechanistic understanding: repeated nocturnal hypoxia in OSA drives hypertension through sustained sympathetic activation, promotes endothelial dysfunction through oxidative stress and reduced nitric oxide bioavailability, stimulates atrial remodeling that predisposes to atrial fibrillation, produces cardiac structural changes — left ventricular hypertrophy, diastolic dysfunction — through chronic pressure overload, and elevates systemic inflammatory markers including hsCRP and IL-6. OSA is not simply a sleep disorder. It is a nocturnal cardiovascular disease.

The mortality data is unambiguous. A landmark observational study by Marin and colleagues published in The Lancet in 2005 followed 264 men with severe OSA over ten years and found that fatal cardiovascular events occurred at a rate of 2.87 per 100 patient-years in untreated patients — compared to 0.35 per 100 patient-years in patients treated with continuous positive airway pressure, or CPAP. That is an eightfold difference in fatal cardiovascular events. CPAP treatment essentially abolished excess cardiovascular mortality in severe OSA in this cohort.

I need to add an honest qualifier here, because the literature also includes a study that is sometimes cited to minimize the cardiovascular consequences of OSA, and I would rather address it directly than let it become a reason not to act. The SAVE trial, published in the New England Journal of Medicine in 2016, randomized 2,717 patients with moderate-to-severe OSA and established cardiovascular disease to CPAP versus usual care and found that CPAP did not reduce the primary composite cardiovascular endpoint. The finding is real and clinically important — but the Marin and SAVE data are not in conflict if you read the studies carefully. SAVE enrolled patients with established cardiovascular disease, and critically, CPAP adherence in that trial averaged only 3.3 hours per night — well below the therapeutic threshold. The implication is that CPAP needs to be initiated earlier, before established cardiovascular disease develops, and used more consistently than the trial achieved. The Marin data, from men without established CVD who were adequately treated, is the more relevant dataset for the reader of this book.

The Snoring You’ve Been Told About

I want to address snoring directly, because I have watched men dismiss it as a social nuisance for years while it was quietly doing cardiovascular work on them.

Snoring — regular, loud snoring, the kind a partner in another room can hear — is not benign. It is the auditory signature of partial upper airway obstruction, and in a significant proportion of men who snore, that obstruction crosses the threshold into clinically significant apnea. The snoring itself produces vibration-mediated injury to the carotid artery walls, independently of any oxygen desaturation. Studies of carotid intima-media thickness — a direct measure of subclinical atherosclerosis — have found increased carotid wall thickening in habitual snorers even when their formal AHI does not meet the diagnostic threshold for OSA.

When your partner tells you that you snore, that information belongs in a physician’s office. Not next month. Not when things calm down. When you have your next interaction with a physician — whether that is a physical, a blood pressure check, or a follow-up for anything — you say: “My partner tells me I snore. Sometimes she says I seem to stop breathing and then start again. What should I do about that?”

What should happen next is a referral for a sleep study. Home sleep studies — which can now be conducted in your own bed with a device worn on the wrist or finger — have made this process substantially more accessible than it was ten years ago. You do not need to sleep in a laboratory. The test measures oxygen levels throughout the night, breathing effort, and a range of physiological signals that allow a sleep physician to calculate your AHI and determine whether treatment is indicated.

The men most likely to have significant OSA and believe they sleep fine have a recognizable profile: male, overweight with neck circumference above sixteen inches, in their forties or fifties, high-stress occupation, snoring reported by partner. This is also the readership of this book. If you are reading this and the description fits, you are a candidate for a sleep study, and I am telling you this as the clinician who will be sitting across from your hypothetical future cardiologist explaining that we had this conversation years ago.

The STOP-BANG Screen

There is a validated eight-question screening tool for obstructive sleep apnea called the STOP-BANG questionnaire. It takes ninety seconds. I use it in my clinic. Let me give it to you.

STOP-BANG:

• S — Snoring: Do you snore loudly (louder than talking, or loud enough to be heard through closed doors)?
• T — Tired: Do you often feel tired, fatigued, or sleepy during the daytime?
• O — Observed: Has anyone observed you stop breathing or choking/gasping during your sleep?
• P — Pressure: Do you have or are you being treated for high blood pressure?
• B — BMI: Is your BMI greater than 35?
• A — Age: Are you older than 50?
• N — Neck circumference: Is your neck circumference greater than 40 cm (approximately 16 inches)?
• G — Gender: Are you male?

A score of three or more is associated with high risk for moderate-to-severe OSA and warrants formal sleep study. Among the men reading this book — who are likely male, in their forties or fifties, and a substantial proportion of whom carry the other risk factors — a score of two just from gender and age is the floor. Add snoring, fatigue, or a history of reported breathing pauses and the screen is effectively positive.

The STOP-BANG is not a diagnosis. It is an indication for evaluation. And the evaluation — a home or laboratory sleep study — is a straightforward, covered medical investigation that takes one night. The resistance to getting one is not about the test. It is about the same reluctance that runs through everything we’ve discussed in this book: the preference for not knowing over the discomfort of knowing.

I understand that preference. I do not recommend acting on it.

Sleep Deprivation as Its Own Vascular Insult

Beyond OSA and the HPA-driven 3 a.m. pattern, there is a third sleep story that needs to be told: the straightforward cardiovascular consequence of insufficient sleep duration and quality in men who have neither OSA nor significant cortisol dysregulation — just not enough time in bed.

The evidence on sleep duration and cardiovascular risk is now substantial enough to belong in any serious discussion of preventive cardiology. A prospective study by Punjabi and colleagues published in PLOS Medicine in 2009 following nearly 1,500 men and women found that sleep-disordered breathing — a category that includes both OSA and fragmented sleep — was associated with significantly increased all-cause mortality after controlling for traditional cardiovascular risk factors. Among men specifically, the mortality associations were strongest and most consistent.

Mechanistically, short sleep duration — defined in most studies as fewer than six hours per night — is independently associated with elevated blood pressure, increased insulin resistance, elevated hsCRP as a marker of systemic inflammation, and reduced glucose tolerance. Each of these is a cardiovascular risk factor, and their combination in a sleep-deprived man represents the same metabolic substrate as early metabolic syndrome.

The slow-wave sleep collapse that occurs naturally in men as they age between thirty-five and fifty-five deserves specific attention here. Slow-wave sleep — the deep Stage 3 NREM sleep — constitutes roughly twenty to twenty-five percent of total sleep time in young adults and declines to less than ten percent by age fifty-five in many men, with the steepest part of that decline occurring between thirty-six and fifty. This is physiologically normal, but it has clinical consequences: slow-wave sleep is when growth hormone is secreted, when insulin sensitivity is reset for the following day, and when the cardiac sympathetic system achieves its deepest quiet. A man who reports eight hours of sleep but whose slow-wave sleep has collapsed to five percent is, in many physiological respects, sleeping four hours. His blood pressure, his testosterone, his glucose regulation, and his cardiovascular stress response are all receiving less recovery than his sleep diary suggests.

The review by Liu and colleagues published in Reviews in Endocrine and Metabolic Disorders in 2022 synthesized the sleep-testosterone-cortisol triad: sleep loss and disrupted architecture are associated with lower morning, afternoon, and twenty-four-hour testosterone levels and higher afternoon cortisol, with these reciprocal changes impairing anabolic-catabolic signaling across multiple metabolic systems. The man running on five or six hours of fragmented sleep is not merely tired. He is operating with a hormonal profile that compounds every other cardiovascular risk this book has described.

What Sleep Medicine Has Learned About Night-Shift Men and Social Jet Lag

I want to add one more dimension to the sleep picture that affects a specific subset of this book’s readers: the man whose schedule creates what chronobiologists call circadian misalignment.

Circadian misalignment occurs when the timing of sleep is persistently out of phase with the body’s internal clock — either because of shift work, frequent long-haul travel across time zones, or what researchers call social jet lag: the discrepancy between when you naturally want to sleep and when your work schedule forces you to. A 2012 meta-analysis by Vyas and colleagues published in the BMJ, covering over two million workers across thirty-four studies, found that shift workers had a twenty-three percent higher risk of myocardial infarction and a twenty-four percent higher risk of coronary events compared to day workers, independent of socioeconomic status.

For the professional man who is not a shift worker but who travels four days per week, finishes work at eleven at night, or consistently sleeps six to seven hours on weekdays and attempts to recover on weekends, some version of circadian misalignment is present. The body’s peripheral clocks — in the liver, the vasculature, the myocardium itself — are calibrated to the central hypothalamic clock, and when social schedules create chronic misalignment between the two, the cardiovascular consequences are measurable and meaningful.

This is not an argument for a perfect schedule. It is an argument for taking sleep irregularity as seriously as you take diet or exercise, and for recognizing that the biological cost of irregularity is not zero.

Clinical Pearl — If you read nothing else in this chapter: Obstructive sleep apnea — which affects an estimated twenty to thirty percent of men between thirty-five and fifty-five and is underdiagnosed in professional populations by a rate greater than eighty percent — is independently associated with a two- to nearly threefold increase in fatal cardiovascular events in untreated patients compared to adequately treated patients, based on ten-year observational data from Marin et al. in The Lancet, 2005. The diagnosis requires a sleep study — which can now be conducted at home in a single night. Many men with significant OSA describe their sleep as “fine” or “okay.” The partner who mentions snoring and witnessed breathing pauses is providing a clinical history. That history belongs in a physician’s office.

Permission Paragraph

I want to give you permission to count the nights. You know the ones I mean. Not the occasional late night from a work deadline, which is familiar and almost comfortable — but the pattern. The wakeups. The middle-of-the-night mind-activation. The mornings that never arrive as rest, just as a continuation of the previous day at reduced clarity. You have probably decided this is simply how your life is right now, and that it will improve when things calm down, when the project ends, when the quarter closes, when the kids get older. I have heard every version of this sentence in my clinic, and I have learned to hear it as what it actually is: a reasonable man applying a reasonable coping framework to what is, in clinical reality, not a coping problem but a physiological finding. The sleep issue is not just a result of how you’re living. In many cases, it is a clinical condition — possibly a diagnosable and treatable one — that is compounding every other cardiovascular risk in this book, every single night, while you try to get back to sleep. Counting the nights is the first step toward doing something about them.

Marcus, 51, chief operating officer at a regional healthcare system, presents for a follow-up on blood pressure that has been difficult to control on two medications. His most recent reading in the office was 144/90. He is not obese — BMI 28 — but carries a collar size of seventeen. His wife has told him repeatedly that he snores; he mentions this at the end of the visit as an aside. He describes sleeping “six or seven hours” and says he feels “tired a lot, but that’s just the job.” He has never had a sleep study. His STOP-BANG score, calculated during the visit, is five out of eight. A home sleep study ordered that afternoon returns an AHI of twenty-two events per hour — moderate obstructive sleep apnea. Four months on CPAP, used consistently, his blood pressure is controlled on a single medication, morning fatigue has substantially improved, and his wife has moved back into the bedroom. He is not a dramatic case. He is the typical case.

What to Do This Week

1. Complete the STOP-BANG questionnaire above and write down your score. If it is three or higher, ask your physician at your next interaction — or by message this week — about a referral for a home sleep study. This is a medical evaluation, not a lifestyle assessment.

2. For the next seven nights, note the time you wake up if you wake in the middle of the night, and write one word describing the quality of your mental state at that moment (e.g., “alert,” “anxious,” “racing,” “neutral”). After seven days, look at the pattern. This is clinical data, not journaling.

3. Ask the person who shares your bedroom — a partner, or anyone who has heard you sleep — whether you snore regularly, and whether they have ever noticed you pause in breathing or gasp. If the answer to either is yes, that information needs to go to your physician, not back into the category of minor annoyances.

Transition to Chapter 6

You have been to a doctor. You’ve had your cholesterol checked. They told you your LDL was fine. They were looking at the wrong number — and in Chapter 6, I’ll tell you what the right number is, why it is almost certainly not on any report you’ve ever received, and why that gap exists between what the evidence says about lipid risk and what is ordered in the average primary care visit.